• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Piedmont Atlanta first in Georgia to offer new minimally invasive treatment for emphysema

Bioengineer by Bioengineer
May 23, 2019
in Health
Reading Time: 2 mins read
1
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Pulmonx

Atlanta, Ga. (May 23, 2019) – Piedmont Atlanta Hospital is the first in the state of Georgia to offer a new minimally invasive treatment for emphysema, a severe form of Chronic Obstructive Pulmonary Disease (COPD).

The procedure improves patients’ quality of life by allowing them to breathe easier, be less short of breath and be more active and energetic. The treatment, using the Zephyr® Valve System, is groundbreaking because it is the first FDA-approved procedure for emphysema that is minimally invasive, meaning no incision or cutting is required.

“This new treatment option is a life-changer for people with emphysema and severe COPD,” said Ralitza Martin, M.D., an interventional pulmonologist with Piedmont Pulmonary, Critical Care and Sleep Medicine and the first physician in the state to perform this procedure. “Until now, the only other options for these patients were highly invasive treatments such as surgical lung volume reduction or lung transplantation. This minimally invasive procedure offers new hope for patients who remain symptomatic despite optimal medical care.”

COPD and specifically emphysema is a progressive and life-threatening lung disease usually caused by smoking. There is no cure and patients live with severe shortness of breath. Simple daily activities like walking or taking a shower are often very difficult.

This extreme shortness of breath is caused when air becomes trapped in parts of the lung that are damaged by the disease. This trapped air causes the damaged areas of the lungs to get larger, which puts pressure on the healthy parts of the lungs and diaphragm. This procedure places tiny valves in the airways to block off the damaged areas of the lung so air is no longer trapped there, allowing the healthier parts of the lungs to expand so patients can breathe more easily.

“We’ve been doing this procedure for several months now and I have seen a dramatic improvement in the quality of life of patients who have been treated,” said Dr. Martin. “It’s incredibly rewarding to see patients who were previously unable to walk down a hallway regain the ability to go outside and spend time with family and friends.”

In clinical studies, patients treated with the Zephyr® Valve System have been shown to breathe easier, be more active and energetic, be less short of breath and enjoy a significantly improved quality of life compared to untreated patients.

###

To learn more about the procedure visit pulmonx.com. To determine eligibility for the procedure, contact Piedmont Atlanta’s Interventional Pulmonary team at [email protected] or call 404-605-3904.

Media Contact
Meghan K. Oreste
[email protected]

Original Source

https://www.piedmont.org/about-piedmont-healthcare/media-room/stories/news-article?story=4234&type=1

Tags: Internal MedicineMedicine/HealthPulmonary/Respiratory MedicineSurgeryTransplantation
Share12Tweet8Share2ShareShareShare2

Related Posts

Comparing Valoctocogene and Efanesoctocog in Hemophilia A

September 9, 2025

Novel CNN Identifies P-glycoprotein Drug Ligands

September 9, 2025

Gut Microbiome Shapes Key Proteins Linked to Aging and Disease

September 9, 2025

Common Genes Influence Monogenic Diabetes Risk, Symptoms

September 9, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • Physicists Develop Visible Time Crystal for the First Time

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Optimizing Cobalt-60 Brachytherapy in Resource-Limited Areas

Evolving Rubisco Solubility Boosts Plant Productivity

Paecilomyces lilacinus: Enhancing Vegetable Growth, Controlling Meloidogyne

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.